Standard
Dichloridobis[3-(4-methoxyphenyl)-2-methyl-5-(piperidin-1-yl)-2,3-dihydro-1,2,4-oxadiazole-κN 4]platinum(II). / Kritchenkov, A.S.; Lavnevich, L.V.; Starova, G.L.; Bokach, N.A.; Kalibabchuk, V.A.
в:
Acta Crystallographica Section E: Structure Reports Online, 2013, стр. m435-m436.
Результаты исследований: Научные публикации в периодических изданиях › статья
Harvard
Kritchenkov, AS, Lavnevich, LV
, Starova, GL, Bokach, NA & Kalibabchuk, VA 2013, '
Dichloridobis[3-(4-methoxyphenyl)-2-methyl-5-(piperidin-1-yl)-2,3-dihydro-1,2,4-oxadiazole-κN 4]platinum(II)',
Acta Crystallographica Section E: Structure Reports Online, стр. m435-m436.
https://doi.org/10.1107/S1600536813018059
APA
Kritchenkov, A. S., Lavnevich, L. V.
, Starova, G. L., Bokach, N. A., & Kalibabchuk, V. A. (2013).
Dichloridobis[3-(4-methoxyphenyl)-2-methyl-5-(piperidin-1-yl)-2,3-dihydro-1,2,4-oxadiazole-κN 4]platinum(II).
Acta Crystallographica Section E: Structure Reports Online, m435-m436.
https://doi.org/10.1107/S1600536813018059
Vancouver
Author
BibTeX
@article{d311d30288414c72a1606b896ec9e5b3,
title = "Dichloridobis[3-(4-methoxyphenyl)-2-methyl-5-(piperidin-1-yl)-2,3-dihydro-1,2,4-oxadiazole-κN 4]platinum(II)",
author = "A.S. Kritchenkov and L.V. Lavnevich and G.L. Starova and N.A. Bokach and V.A. Kalibabchuk",
year = "2013",
doi = "10.1107/S1600536813018059",
language = "English",
pages = "m435--m436",
journal = "Acta Crystallographica Section E: Crystallographic Communications",
issn = "2056-9890",
publisher = "International Union of Crystallography",
}
RIS
TY - JOUR
T1 - Dichloridobis[3-(4-methoxyphenyl)-2-methyl-5-(piperidin-1-yl)-2,3-dihydro-1,2,4-oxadiazole-κN 4]platinum(II)
AU - Kritchenkov, A.S.
AU - Lavnevich, L.V.
AU - Starova, G.L.
AU - Bokach, N.A.
AU - Kalibabchuk, V.A.
PY - 2013
Y1 - 2013
U2 - 10.1107/S1600536813018059
DO - 10.1107/S1600536813018059
M3 - Article
SP - m435-m436
JO - Acta Crystallographica Section E: Crystallographic Communications
JF - Acta Crystallographica Section E: Crystallographic Communications
SN - 2056-9890
ER -